abstract |
The present invention provides a method for treating, and compositions useful for treating, Flavivirus infections in a human by administering to the human an effective amount of mRNA encoding Mus musculus resistant 2′-5′ oligoadenylate synthetase 1b (rOas1b), or variants thereof. |